ProPhase Labs, Inc.
PRPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000868278
No open-market purchases or sales by ProPhase Labs, Inc. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $2 in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding ProPhase Labs, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 21 | 25 | +4 |
| Shares | 1.65M | 1.51M | −137.3K (−8.3%) |
| Value | $8.56M | $10.8M | +$2.26M (+26.4%) |
New holders (10)
Institutions that held ProPhase Labs, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ameriprise Financial Inc | 134,651 | $964.0K | 0.00% |
| Group One Trading, L.P. | 3,400 | $24.0K | 0.00% |
| UBS Group AG | 1,868 | $13.0K | 0.00% |
| Simplex Trading, LLC | 1,548 | $11.0K | 0.00% |
| The PNC Financial Services Group, Inc. | 600 | $4.00K | 0.00% |
| Royal Bank of Canada | 500 | $4.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 370 | $3.00K | 0.00% |
| North Star Investment Management Corp. | 100 | $1.00K | 0.00% |
| CoreCap Advisors, LLC | 100 | $1.00K | 0.00% |
| Dixon Hughes Goodman Wealth Advisors LLC | 175 | $1.00K | 0.00% |
Sold out (6)
Institutions that held ProPhase Labs, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Bank of Montreal | 158,587 | $821.0K |
| Kamunting Street Capital Management, L.P. | 98,888 | $514.0K |
| Susquehanna International Group, LLP | 31,487 | $164.0K |
| Marshall Wace, LLP | 22,801 | $119.0K |
| HighVista Strategies LLC | 20,256 | $105.0K |
| JPMorgan Chase & Co | 5,730 | $30.0K |